⌘K

Home/Filings/4/0001123292-20-000463

4//SEC Filing

Bingham James B. 4

Accession 0001123292-20-000463

CIK 0001661059other

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:38 PM ET

Size

5.3 KB

Accession

0001123292-20-000463

Insider Transaction Report

Form 4

Period: 2020-02-28

NextCure, Inc.NXTC

Bingham James B.

Chief Development Officer

Transactions

Award
Employee Stock Option (Right to Buy)
2020-02-28+78,200→ 78,200 total
Exercise: $41.76Exp: 2030-02-27→ Common Stock (78,200 underlying)

Footnotes (1)

[F1]One fourth of the option vests on February 28, 2021. The remainder vests in 36 monthly installments beginning on March 28, 2021.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

NextCure, Inc.

CIK 0001661059

Entity typeother

Related Parties

1

filerCIK 0001775735

Filing Metadata

Form type: 4
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 4:38 PM ET
Size: 5.3 KB

View on SEC.gov